<< Crystallized molecular machine reveals possible new paths for treating diseases | New compound, AMN107, 20 times more potent than Gleevec for chronic myelogenous leukemia treatment >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | Nederlands | Finnish | Русский | Polski

Female sex hormones have a profound effect on susceptibility to the herpes simplex virus

Published on February 21, 2005 at 6:40 AM · 1 Comment

Two McMaster University studies, to be published in the Journal of Virology, show that sex hormones have a profound effect on susceptibility of female mice to the herpes simplex virus, type 2 (HSV-2 ), one of the most common sexually transmitted diseases.

Charu Kaushic, assistant professor and supervisor of the studies, says the implication of this work is quite significant. “The research clearly shows, and reaffirms previous research, that in female mice, sex hormones have a profound effect on susceptibility to sexually transmitted infections as well as on the body's defense mechanisms against them.”

One of the many implications of these findings she says, is that if future studies can figure out that women too, like mice, are protected in primary exposure by estradiol, contraceptive creams could be formulated that would prevent herpes virus infection before they could start. Additionally she says, if they were designing a vaccine trial against HSV-2 and if the mice results hold true for women, they could suggest vaccination protocols under combination hormone therapy to get the best benefit from the vaccine.

Work in this area is important because one in every four sexually active adults is seropositive for HSV-2 and women are much more susceptible than men.

“The results directly indicate that the hormonal conditions that provide protection against primary exposure to sexually transmitted viral infections may be very different than those that may be useful in vaccination strategies,” said Kaushic.

“There is of course the flip side to this as well. Our studies in mice and in fact a number of clinical studies as well show that women who use Depo-provera, a progesterone based injectable contraceptive, have particularly high susceptibility to sexually transmitted infections, including HIV-1 and HSV-2. We do not understand why, and our hope is that by doing these kind of mouse studies, we can understand the mechanisms.”

In the first study, female mice received either the hormone estradiol or progesterone, a combination of both, or nothing at all prior to exposing them to the herpes virus. Both estradiol and progesterone are natural hormones found in the body.

The estradiol-treated mice were protected 100 percent, whereas the progesterone-treated mice and mice that didn’t receive any hormones, showed extensive infection, and additionally, the progesterone-treated mice had increased inflammation and were more susceptible to the virus. The mice treated with a combination of the two hormones, estradiol and progesterone, were protected, but only if the virus doses were weakened.

Comments
  1. Pissed off Pissed off United States says:

    I just read the studies of mice given Depoprovera and then getting herpes. Well, guess what? It is TRUE! How do I know, well it happened to me. After just ONE shot, a few weeks later I ended up with Type 2 Herpes. And, I only have one partner. He has had cold sores in the past, but hasn't had one in over a year. And I end up getting herpes through oral sex. What the hell? No one told me this was an increased risk. Not Planned Parenthood and it says NOTHING on the Depoprovera information from the company. I am an innocent person who now has a disease that has no cure and never goes away. I am going to get me a lawyer because this is neglect on their part. Believe me, I will get my revenge!! And if anyone else has had this happen, please leave a comment with your story and email address.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading